NASDAQ: EXASExact Sciences Corp Stock Ownership - Who owns Exact Sciences?
Insider buying vs selling
Have Exact Sciences Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jacob A. Orville | General Manager Screening | 2023-03-03 | 5,000 | $65.00 | $325.00kSell |
| Sarah Condella | EVP Human Resources | 2023-03-01 | 1,000 | $62.00 | $62.00kSell |
| Everett Cunningham | Chief Commercial Officer | 2023-03-01 | 3,628 | $62.01 | $224.97kSell |
| Kevin T. Conroy | President and CEO | 2023-02-28 | 10,416 | $61.12 | $636.63kSell |
| Jacob A. Orville | General Manager Screening | 2023-02-28 | 1,832 | $61.12 | $111.97kSell |
| James Herriott | General Counsel | 2023-02-28 | 875 | $61.12 | $53.48kSell |
| Jeffrey Thomas Elliott | Chief Financial Officer | 2023-02-28 | 4,233 | $61.12 | $258.72kSell |
| Sarah Condella | EVP Human Resources | 2023-02-28 | 2,924 | $61.12 | $178.71kSell |
| D. Scott Coward | Director | 2023-02-28 | 4,153 | $61.12 | $253.83kSell |
| Brian Baranick | Gen. Mgr. Precision Oncology | 2023-02-28 | 1,932 | $61.12 | $118.08kSell |
EXAS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when EXAS insiders and whales buy or sell their stock.
EXAS Shareholders
What type of owners hold Exact Sciences Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 9.68% | 17,252,465 | $1.09B | Institution |
| Ark Investment Management LLC | 9.00% | 16,040,490 | $1.02B | Institution |
| Blackrock Inc | 6.37% | 11,354,558 | $720.33M | Institution |
| Wellington Management Group LLP | 5.75% | 10,251,938 | $650.38M | Institution |
| Jpmorgan Chase Co | 4.35% | 7,749,716 | $491.64M | Institution |
| Sumitomo Mitsui Trust Holdings Inc | 3.01% | 5,364,599 | $340.33M | Institution |
| Capital World Investors | 2.91% | 5,191,387 | $329.34M | Institution |
| State Street Corp | 2.91% | 5,178,803 | $328.54M | Institution |
| Price T Rowe Associates Inc | 2.80% | 4,992,367 | $316.72M | Institution |
| Baillie Gifford Co | 2.77% | 4,931,262 | $312.84M | Institution |
EXAS vs Diagnostic & Research Stocks
Exact Sciences Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.